Mansalinog, Emilyn B.
HRN: 22-26-8401 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/02/2023
METRONIDAZOLE 500MG (TAB)
01/02/2023
01/08/2023
ORAL
500 Mg
TID
AMOEBIASIS
Waiting Final Action
Indication: Empiric Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes